💊 Amazon Prime pills

…and Microsoft’s not-so-excellent earnings beat [Disclosures](   Adding pharmacy to cart (Igor Golovniov/Getty Images)   Yesterday’s Market Moves   Dow Jones 33,734 (+0.31%) S&P 500 4,017 (-0.071%) Nasdaq 11,334 (-0.27%) Bitcoin $22,760 (-0.87%) Dow Jones 33,734 (+0.31%) S&P 500 4,017 (-0.071%) Nasdaq 11,334 (-0.27%) Bitcoin $22,760 (-0.87%) Hey Snackers, Breakfast with a side of fresh cash? An Indiana [McDonald’s]( [accidentally]( gave a customer a bag filled with $5K instead of his McMuffin. The man returned the money, went viral on TikTok, and said he was rewarded with a month of free McD’s. Someone call [John Quiñones](. Stocks closed mixed yesterday as investors digested earnings from corporates like [Johnson & Johnson]( and [3M](. Next up: all eyes are on tomorrow's fourth-quarter GDP data. RX Amazon unveils a $5/month unlimited meds subscription as retailers race into pill delivery A pack of migraine meds… with your monthly TP delivery. [Amazon]( doubling down on its pharmacy biz with a [new]( prescription-drug subscription. Prime members can now buy unlimited meds (and get ’em delivered to their doorstep) for a flat fee of $5/month — no insurance necessary. The subscription (dubbed “RXPass”) offers 80 medications for everything from high blood pressure to anxiety. Amazon’s targeting people who are juggling numerous prescriptions: 150M+ Americans take one or more of the drugs included in the RXPass. - Look back: Amazon [bought]( online pharmacy PillPack for $750M in 2018 and splurged nearly $4B on membership-based health-clinic chain [One Medical]( last year. - Pill pack: So far only 14% of prescription customers know about Amazon’s PillPack online pharmacy, but over a third say they plan to switch pharmacies in the next year. Getting crowded… Nearly half of US adults take two or more meds daily, and a quarter say it’s difficult to afford the treatment they need. Now retailers are scrambling to get more prescription business. In 2021 [Walmart]( added prescription discounts to its Walmart+ membership program. Mark Cuban’s discounted Cost Plus e-pharmacy attracted 1.5M customers just a year after launching. Meanwhile, [CVS]( and [Walgreens]( have ramped up their prescription offerings with features like mobile ordering and delivery. Amazon’s big differentiator: offering many drugs at one flat rate. THE TAKEAWAY Old roads can open new paths… Amazon’s been moving into healthcare for years, but has yet to make a big mark in the $500B pharmacy retail space. Now it’s using its “old road” strengths (think: 168M Prime subscribers and a massive delivery network) to get ahead. Its bid is promising: nearly two-thirds of brick-and-mortar pharmacy customers have a Prime account. Word Microsoft reports slowing growth and a rare profit drop, but is still investing billions Soft landing… [Microsoft]( kicked off Big Tech earnings yesterday on an upbeat note. Shares of the software titan spiked 4% after it reported (slightly) better-than-expected earnings, courtesy of solid cloud growth. Microsoft’s cloud-computing unit — aka: the second-largest cloud biz after Amazon’s AWS — grew revenue by 31% from last year, a slowdown from previous quarters. Investors were uplifted by the small earnings beat, but Microsoft’s reality is not so suite: - Far from Excel-ent: Total sales grew at the slowest pace since 2016, and profit dropped for the first time in eight years (from $18.7B last year, to $16.4B). - Iffy Outlook: Last week Microsoft said it was slashing 10K workers to prepare for a recession as the remote-work boom wanes. New year, new me… Microsoft is the first of the Big Tech Five ([Apple]( Amazon, [Google]( Microsoft, [Meta]( to report. In 2021, they [demolished]( earnings with jaw-dropping records. In May of that year, Microsoft posted its strongest revenue growth since 2018, while Apple and Amazon delivered quarterly records. This year, it’s a different story: - The remaining four of the Big Tech Five are also expected to release lower quarterly earnings as demand slows, recession fears grow, and layoffs abound. THE TAKEAWAY When the going gets tough, get more going… Even as cloud and PC demand slows, Microsoft’s not backing down from big spending: it just announced a multiyear, multibillion-dollar investment in ChatGPT maker OpenAI — and is still aggressively [trying]( to complete its $69B acquisition of gaming company [Activision Blizzard](. By doubling down on generative-AI tools and gaming, Microsoft’s hoping to energize growth with new tech. What else we're Snackin' - [Walmore]( Walmart, aka America’s largest employer, said it's raising its minimum wage for store staff to $14/hour. The goal: attract and retain workers in a still competitive job market. - [Googopoly]( The Justice Department sued Google, saying it has a monopoly over online advertising tech. It's the fifth govt antitrust suit against the search giant since 2020, and aims to make Google sell off its ad tech. - [3Miss]( 3M announced it's laying off 2.5K employees as demand for disposable face masks sags. The Minnesota biz manufactures everything from Post-its to Scotch tape to "forever chemicals." - [Vaxing]( Johnson & Johnson said its quarterly earnings dropped 25% as global demand for its Covid vax sank 57%. Still, sales of its over-the-counter meds like Tylenol got a boost during flu season. - [Whynance]( Crypto exchange Binance said it was a "mistake" to keep customers' funds and collateral for its tokens in the same digital wallet. Meanwhile, regulators [said]( exchanges shouldn't mix their crypto with customers'. 🍪 Thanks for Snacking with us! Want to share the Snacks? Invite your friends to sign up [here](. Snack Fact Of the Day Scientists captured a radio signal that was emitted from a distant galaxy 8B+ years ago [Read more]( Wednesday - Earnings expected from Tesla, Abbott Labs, AT&T, Boeing, NextEra Energy, Kimberly Clark, Levi, and IBM Authors of this Snacks own shares of: Amazon, Apple, CVS, Google, Microsoft, Walmart and Tesla ID: 2699644 Robinhood Snacks newsletters reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC (Member [SIPC]( and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are for informational purposes only, and are not a recommendation of an investment strategy or to buy or sell any security, digital asset (cryptocurrency, etc) in any account. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk including the loss of principal and past performance does not guarantee future results. [Robinhood Terms and Conditions]( • [Disclosure Library]( • [Our Editorial Principles]( • [Contact Us]( • [FAQ]( [Manage Your Subscription Preferences](